Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
76,625.97
(
-0.08%
)
News Focus
News Focus
Post# of 31
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

StockLogistics

Send PM Follow Ignore
Followers 40
Posts 5751
Boards Moderated 0
Alias Born 04/12/2021

StockLogistics

Re: None

Sunday, 10/17/2021 4:40:48 PM

Sunday, October 17, 2021 4:40:48 PM

Post# of 31
2022 stock, no revenue this year as per company statements imo :

“6:16a ET 8/10/2021 - Benzinga
Nautilus Biotechnology Q2 EPS $(0.19) Misses $(0.09) Estimate

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.09) by 111.11 percent.

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”

my posts are always theory and not financial advice

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NAUT News
More NAUT News